Acorn AI

Acorn AI is the data science and artificial intelligence division of Medidata, a Dassault Systèmes company. Launched in 2019, the company leverages one of the industry's largest pools of clinical trial data to provide actionable insights across the drug development lifecycle. Its core offerings include Synthetic Control Arms (SCA), which use historical trial data to reduce the need for placebo groups, and Intelligent Trials for optimizing site selection and enrollment. Acorn AI's platform integrates clinical and commercial data to help life sciences companies improve R&D productivity and demonstrate the value of their therapies. By applying advanced analytics to over 20,000 clinical trials, the company helps sponsors mitigate risk and accelerate the delivery of new treatments to patients.